Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: How to differentiate local from systemic disease? The urologist point of view

Revista Espanola de Medicina Nuclear e Imagen Molecular

Volumn 32, Issue 5, 2013, Pages 310-313

  Schiavina, R ^a   Brunocilla, E ^a   Borghesi, M ^a   Vagnoni, V ^a   Castellucci, P ^a   Nanni, C ^a   Ceci, F ^a   Gacci, M ^b   Martorana, G ^a   Fanti, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; PROSTATE SPECIFIC ANTIGEN;

CANCER PATIENT; CANCER RECURRENCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; GLEASON SCORE; MICRO-COMPUTED TOMOGRAPHY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPH NODE; PELVIS; POSITRON EMISSION TOMOGRAPHY; PROSTATE; PROSTATE CANCER; SENSITIVITY ANALYSIS; SPINE; TRANSRECTAL ULTRASONOGRAPHY; UROLOGIST;

ADENOCARCINOMA; CARBON RADIOISOTOPES; CARBOXYLIC ACIDS; CHOLINE; COMBINED MODALITY THERAPY; CYCLOBUTANES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; UROLOGY;

EID: 84883264467     PISSN: 2253654X     EISSN: 22538070     Source Type: Journal    
DOI: 10.1016/j.remn.2013.06.003     Document Type: Note

References (21)

1. Rouvière O. Imaging techniques for local recurrence of prostate cancer: for whom, why and how?. Diagn Interv Imaging 2012, 93:279-290. [review].
2. Pfitzenmaier J., Pahernik S., Tremmel T., Haferkamp A., Buse S., Hohenfellner M. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression. BJU Int 2008, 102:1413-1418.
3. Brunocilla E., Pultrone C., Pernetti R., Schiavina R., Martorana G. Preservation of the smooth muscular internal (vesical) sphincter and of the proximal urethra during retropubic radical prostatectomy: description of the technique. Int J Urol 2012, 19:783-785.
4. Mattei A., Fuechsel F.G., Bhatta Dhar N., Warncke S.H., Thalmann G.N., Krause T., et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol 2008, 53:118-125.
5. Murphy A.M., Berkman D.S., Desai M., Benson M.C., McKiernan J.M., Badani K.K. The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy. BJU Int 2009, 105:176.
6. Schiavina R., Manferrari F., Garofalo M., Bertaccini A., Vagnoni V., Guidi M., et al. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer. BJU Int 2011, 108:1262-1268.
7. Bubendorf L., Schöpfer A., Wagner U., Sauter G., Moch H., Willi N., et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000, 31:578-583.
8. Russell M.R., Liu Q., Lei H., Kazlauskas A., Fatatis A. The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms. Cancer Res 2010, 70:4195-4203.
9. Martino P., Scattoni V., Galosi A.B., Consonni P., Trombetta C., Palazzo S., et al. Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU). World J Urol 2011, 29:595-605.
10. Panebianco V., Sciarra A., Lisi D., Galati F., Buonocore V., Catalano C., et al. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Eur J Radiol 2012, 81:700-708.
11. Arrayeh E., Westphalen A.C., Kurhanewicz J., Roach M., Jung A.J., Carroll P.R., et al. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys 2012, 82:e787-e793.
12. Choueiri T.K., Dreicer R., Paciorek A., Carroll P.R., Konety B. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy. J Urol 2008, 179:906-910.
13. Farsad M., Schiavina R., Franceschelli A., Sanguedolce F., Castellucci P., Bertaccini A., et al. Positron-emission tomography in imaging and staging prostate cancer. Cancer Biomark 2008, 4:277-284.
14. García J.R., Soler M., Blanch M.A., Ramírez I., Riera E., Lozano P., et al. PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer. Rev Esp Med Nucl 2009, 28:95-100.
15. Schiavina R., Martorana G. The promise of Choline-PET/CT in the detection of recurrent prostate cancer: what are the limits of our investigation?. Eur Urol 2013, 63:797-799.
16. 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy. Eur J Radiol 2012, 81:893-896.
17. 11C]choline positron emission tomography/computed tomography. Eur Urol 2011, 60:935-943.
18. Brunocilla E., Pernetti R., Martorana G. The role of pelvic lymph node dissection during radical cystectomy for bladder cancer. Anticancer Res 2011, 31:271-275.
19. 11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen. J Urol 2013, 189:105-110.
20. Ceci F., Castellucci P., Mamede M., Schiavina R., Rubello D., Fuccio C., et al. (11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy. Eur J Nucl Med Mol Imaging 2013, 40:149-155.
21. 11C-Choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results. Eur J Nucl Med Mol Imaging 2013, 40(Suppl 1):11-17.